56 related articles for article (PubMed ID: 23791883)
1. Multiple drug resistant, tumorigenic stem-like cells in oral cancer.
Richard V; Sebastian P; Nair MG; Nair SN; Malieckal TT; Santhosh Kumar TR; Pillai MR
Cancer Lett; 2013 Sep; 338(2):300-16. PubMed ID: 23791883
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma.
Biddle A; Gammon L; Liang X; Costea DE; Mackenzie IC
EBioMedicine; 2016 Feb; 4():138-45. PubMed ID: 26981578
[TBL] [Abstract][Full Text] [Related]
3. JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.
Facompre ND; Harmeyer KM; Sole X; Kabraji S; Belden Z; Sahu V; Whelan K; Tanaka K; Weinstein GS; Montone KT; Roesch A; Gimotty PA; Herlyn M; Rustgi AK; Nakagawa H; Ramaswamy S; Basu D
Cancer Res; 2016 Sep; 76(18):5538-49. PubMed ID: 27488530
[TBL] [Abstract][Full Text] [Related]
4. Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma.
Liu J; Zhao J; Qiao X
Endocrinology; 2023 Sep; 164(11):. PubMed ID: 37738154
[TBL] [Abstract][Full Text] [Related]
5. Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling.
Song J; Chang I; Chen Z; Kang M; Wang CY
PLoS One; 2010 Jul; 5(7):e11456. PubMed ID: 20625515
[TBL] [Abstract][Full Text] [Related]
6. Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time.
Chia S; Low JL; Zhang X; Kwang XL; Chong FT; Sharma A; Bertrand D; Toh SY; Leong HS; Thangavelu MT; Hwang JSG; Lim KH; Skanthakumar T; Tan HK; Su Y; Hui Choo S; Hentze H; Tan IBH; Lezhava A; Tan P; Tan DSW; Periyasamy G; Koh JLY; Gopalakrishna Iyer N; DasGupta R
Nat Commun; 2017 Sep; 8(1):435. PubMed ID: 28874669
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ABCB5 immunostained epithelial stem cells in oral squamous cell carcinoma, inflammatory gingival hyperplasia and normal mucosa.
Aadithi MG; Divya B; Nandhini G; Rajkumar K; Ramesh Kumar A; Sarangarajan R
Biotech Histochem; 2024 Nov; 99(1):44-48. PubMed ID: 38073314
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells biomarkers and the dynamics of the tumor microenvironment in oral squamous cell carcinoma.
Perumal MKK; Renuka RR; Srinivasan GP; Jothinathan MKD
Oral Oncol; 2024 May; 152():106797. PubMed ID: 38608411
[No Abstract] [Full Text] [Related]
9. Luteolin suppresses oral carcinoma 3 (OC3) cell growth and migration via modulating polo-like kinase 1 (PLK1) expression and cellular energy metabolism.
Gao P; Zhang W; Lin Y; Lu R; Lou Z; Lu G; Pan R; Chen Y
J Zhejiang Univ Sci B; 2023 Dec; 24(12):1151-1158. PubMed ID: 38057271
[TBL] [Abstract][Full Text] [Related]
10. Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.
Li CX; Gong ZC; Tan XR
Cancer Immunol Immunother; 2023 Sep; 72(9):3133-3134. PubMed ID: 37149552
[No Abstract] [Full Text] [Related]
11. Cancer stem cells in head and neck squamous cell carcinoma and its associated markers: A review.
Mallika L; Rajarathinam M; Thangavel S
Indian J Pathol Microbiol; 2024 Apr; 67(2):250-258. PubMed ID: 38394427
[TBL] [Abstract][Full Text] [Related]
12. Chronotherapeutics in the management of oral squamous cell carcinoma - A futuristic novel treatment strategy.
Poornachitra P; Muthukrishnan A; Devaraj E
Indian J Cancer; 2023 Oct; 60(4):595-596. PubMed ID: 38185867
[No Abstract] [Full Text] [Related]
13. Orai3 Calcium Channel Contributes to Oral/Oropharyngeal Cancer Stemness through the Elevation of ID1 Expression.
Nguyen A; Sung Y; Lee SH; Martin CE; Srikanth S; Chen W; Kang MK; Kim RH; Park NH; Gwack Y; Kim Y; Shin KH
Cells; 2023 Sep; 12(18):. PubMed ID: 37759448
[TBL] [Abstract][Full Text] [Related]
14. Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators.
Richard V; Nair MG; Jaikumar VS; Jones S; Prabhu JS; Kerin MJ
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834918
[TBL] [Abstract][Full Text] [Related]
15. CD44 Mediates Oral Squamous Cell Carcinoma-Promoting Activity of MRE11 via AKT Signaling.
Yuan SF; Hung AC; Hsu CW; Lan TH; Su CW; Chi TC; Chang YC; Chen YK; Wang YY
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629265
[TBL] [Abstract][Full Text] [Related]
16. The Microenvironment of Tongue Cancer.
Tao W; Li-Juan Z; Kan L; Jing-Yuan L; Xiang-Qi L; Yu-Jie L
Adv Exp Med Biol; 2020; 1296():49-78. PubMed ID: 34185286
[TBL] [Abstract][Full Text] [Related]
17. Transitional dynamics of cancer stem cells in invasion and metastasis.
Richard V; Kumar TRS; Pillai RM
Transl Oncol; 2021 Jan; 14(1):100909. PubMed ID: 33049522
[TBL] [Abstract][Full Text] [Related]
18. The Combination of CD147 and MMP-9 Serum Levels Is Identified as Novel Chemotherapy Response Markers of Advanced Non-Small-Cell Lung Cancer.
Qiao X; Gu Y; Yu J; Wang J; Liu X; Gu M; Ma L; Jia Y; Zhang S
Dis Markers; 2020; 2020():8085053. PubMed ID: 32377273
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches.
Baniebrahimi G; Mir F; Khanmohammadi R
Cancer Cell Int; 2020; 20():113. PubMed ID: 32280305
[TBL] [Abstract][Full Text] [Related]
20. Triptolide reduces proliferation and enhances apoptosis in drug-resistant human oral cancer cells.
Tian L; Zhang Y; Wang Y; Dang R; Fu Z; Gu B; Wen N
Int J Clin Exp Pathol; 2019; 12(4):1204-1213. PubMed ID: 31933935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
